- Home
- CODA vs PROK Comparison
CODA vs PROK Comparison
Compare CODA & PROK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CODA
- PROK
- Stock Information
- Founded
- CODA 1994
- PROK 2015
- Country
- CODA United States
- PROK United States
- Employees
- CODA N/A
- PROK N/A
- Industry
- CODA Industrial Machinery/Components
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CODA Industrials
- PROK Health Care
- Exchange
- CODA Nasdaq
- PROK Nasdaq
- Market Cap
- CODA 88.7M
- PROK 85.5M
- IPO Year
- CODA N/A
- PROK N/A
- Fundamental
- Price
- CODA $8.11
- PROK $0.65
- Analyst Decision
- CODA Strong Buy
- PROK Hold
- Analyst Count
- CODA 1
- PROK 3
- Target Price
- CODA $11.00
- PROK $3.50
- AVG Volume (30 Days)
- CODA 62.6K
- PROK 1.7M
- Earning Date
- CODA 06-16-2025
- PROK 08-08-2025
- Dividend Yield
- CODA N/A
- PROK N/A
- EPS Growth
- CODA 21.86
- PROK N/A
- EPS
- CODA 0.30
- PROK N/A
- Revenue
- CODA $22,758,966.00
- PROK $306,000.00
- Revenue This Year
- CODA $11.64
- PROK $54.34
- Revenue Next Year
- CODA $14.53
- PROK N/A
- P/E Ratio
- CODA $27.03
- PROK N/A
- Revenue Growth
- CODA 24.78
- PROK N/A
- 52 Week Low
- CODA $5.76
- PROK $0.46
- 52 Week High
- CODA $9.89
- PROK $2.59
- Technical
- Relative Strength Index (RSI)
- CODA 61.67
- PROK 43.63
- Support Level
- CODA $7.78
- PROK $0.54
- Resistance Level
- CODA $8.31
- PROK $0.90
- Average True Range (ATR)
- CODA 0.57
- PROK 0.13
- MACD
- CODA 0.05
- PROK -0.02
- Stochastic Oscillator
- CODA 60.98
- PROK 20.25
About CODA Coda Octopus Group Inc. Common stock
Coda Octopus Group Inc develops underwater technologies and equipment for imaging, mapping defense, and survey applications. The company's operations are organized into two reportable segments: the Products Segment (Marine Technology Business serving the subsea market and PAL, which sells other products (acoustic hydrophones and acoustic materials to a different market); and the Services Segment (Marine Engineering Business). Its geographical segments are the Americas, Europe, Australia/Asia, and the Middle East/Africa. The majority of revenue is derived from the Products segment.
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.